Recurrent Covid‐19 Pneumonia in the course of chemotherapy:

alkiviadis.1961 shared this article with you from Inoreader Recurrent Covid‐19 Pneumonia in the course of chemotherapy: consequence of a weakened immune system? Via Journal of Medical Virology Abstract One of the objectives that the scientific community is setting itself is to understand whether acquired immunity and the presence of antibodies against acute coronavirus 2 (SARS‐CoV‐2) antibodies protect against reinfection. Although there are many published papers describing how the re‐positivization of nasopharyngeal swab polymerase chain reaction real time (RT‐PCR) test and clinical healing of the subject can be justified by numerous reasons and random situations. Our aim is to highlight how there are certain populations more susceptible to re‐infection than others. This article is protected by copyright. All rights reserved. View on the web Inoreader. Take back control of your news feed. Follow us on Twitter and Facebook.